Datroway Approved in The EU For Metastatic TNBC ▫️AstraZeneca And Daiichi Sankyo's TROP2-Targeting Drug Datroway Has Been Approved by The European Commission (EC) For Some Previously Untreated Patients With Metastatic Triple-Negative Breast Cancer (TNBC), Its Second Indication. ▫️The Approval Covers The Use of Datroway (Datopotamab Deruxtecan) As A First-Line Monotherapy For TNBC Patients Who Are Not Candidates For …

Channel
Medical News Today
@MedicalNewsToday
On this record: Topic · Growth · Engagement · Posts · Citations · Cite this entry
777subscribers
+4 since we began measuring on 7 August 2026
Risers and fallers across the register · movement among entries of Under 1,000.
Register entry
| Telegram ID | -1001201206293 |
|---|---|
| Type | Channel |
| Username | @MedicalNewsToday |
| Created | Between 1 March 2018 and 31 August 2021 — estimated from Telegram’s id allocation, not measured. How this range is calculated. |
| First recorded | 7 August 2026 |
| Last confirmed live | 10 September 2026 |
| Measurements held | 6 |
| Confirmed unchanged | 1 time, most recently 10 September 2026 |
| On Telegram | t.me/MedicalNewsToday |
Topic
Health & wellness — a classification, not a measurement. An on-box language model (Qwen3.6-35B-A3B-FP8, prompt version 1) read this channel’s own recent posts on 20 September 2026 and assigned it the closest of 31 fixed categories, at 100% confidence. This is a model’s judgement about what the channel is likely to be about, not a fact this register measured the way a subscriber count or a view count is measured — it can be revised on a later pass, and it carries no weight anywhere else on this page. How this classification works, and why it has no browse page of its own yet.
Growth
| Measured (UTC) | Subscribers | Change |
|---|---|---|
| 10 Sept 2026, 20:57 | 777 | +1 |
| 31 Aug 2026, 19:07 | 776 | -3 |
| 23 Aug 2026, 22:08 | 779 | +2 |
| 15 Aug 2026, 08:56 | 777 | +4 |
| 7 Aug 2026, 00:47 | 773 | no change |
| 7 Aug 2026, 00:38 | 773 | first reading |
Engagement
20 posts held, back to 8 June 2026 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 page of Telegram’s post history, 20 posts per page.
Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 20 posts for this entry, the most recent from 3 August 2026. An engagement rate over an empty window would be a number about nothing.
Recent posts
Eating One Avocado A Day May Lower Heart Disease Risk ▫️Eating One Avocado Each Day May Modestly Reduce Heart Disease Risk in Adults With Obesity, According to New Research Led by Scientists in The Penn State Department of Nutritional Sciences. ▫️The Findings Were Published in The Journal of Clinical Lipidology. @MedicalNewsToday
Long Covid Associated With Injury to Dopamine System ▫️Long Covid May Be Associated With Injury to The Dopamine System, According to A New Canadian Study. ▫️The Findings of This Case-Control Study May Explain Symptoms Such As Lack of Motivation Due to Fatigue, Slowed Movement, And Memory Difficulties. They Also Could Open The Door to New Treatment Strategies. ▫️The Current Research Was Prompted by Earlier Findings S…
FDA Licenses First-Ever Freeze-Dried Plasma Product in The US ▫️Vascular Solutions, LLC, Has Been Given US Food And Drug Authority Authorization For Its Ezplaz Freeze Dried Plasma For Transfusion in Adults. ▫️In Larger Domestic Hospitals, Plasma Is Readily Available But in Combat Zones or During Disasters in Remote Areas, Availability of It Could Be Life or Death. ▫️To Help, FDA Has Given The Green Light to Ezplaz T…
EU Panel Backs First Refillable Eye Implant For AMD ▫️A Refillable Ocular Implant That Could Reduce Treatment Frequency For Adults With Stable Neovascular (Wet) Age-Related Macular Degeneration (nAMD) Moved Closer to Approval in The EU After The European Medicines Agency’s Committee For Medicinal Products For Human Use Backed Susvimo (Ranibizumab, Roche Registration GmbH). ▫️The Treatment Is Intended For Patients Wh…
Scientists Discover Why Poor Sleep May Harm Some Brains More ▫️A Gene Involved in The Brain’s Overnight Cleaning System May Change How Strongly Poor Sleep Affects Alzheimer’s-Related Brain Changes. ▫️The Study, Conducted by ECU's Centre For Precision Health (CPH), Examined The Aquaporin-4 (AQP4) Gene. This Gene Helps Control The Movement of Fluid Through The Brain, A Function That Supports The Organ's Natural Waste-…
Tirzepatide Weight Loss Greater in Women vs Men, Age No Link ▫️Among Adults With Overweight or Obesity On Continuous Therapy With Tirzepatide, Women Achieved Greater Total Body Weight Loss (TBWL) Than Men. ▫️It Was Published Online in Obesity. @MedicalNewsToday
WHO Recommends Doxycycline Postexposure Prophylaxis to Prevent Bacterial STIs ▫️The World Health Organization (WHO) Issued Its First Recommendation on The Use of Doxycycline Postexposure Prophylaxis (doxyPEP) to Help Prevent Bacterial Sexually Transmitted Infections (STIs). ▫️The Guidelines Recommend Using doxyPEP As Part of A Comprehensive Sexual Health Strategy That Complements Established Prevention Measures, Inc…
EC Approved Enhertu As First Tumor-Agnostic HER2-Directed ADC ▫️The European Commission (EC) Has Approved AstraZeneca And Daiichi Sankyo’s Enhertu (Trastuzumab Deruxtecan) As A Monotherapy For Adults With Unresectable or Metastatic HER2-Positive, Immunohistochemistry (IHC) 3+, Solid Tumors Who Have Received Prior Treatment And Have No Satisfactory Treatment Options. ▫️This Approval Makes Enhertu The First HER2-Direc…
Statins May Trigger Muscle Side Effects by Activating Inflammatory Danger Signals ▫️A Recent Study Published in The Journal Science Advances Uncovered Biological Mechanisms That Drive Muscle-Related Side Effects Following Statin Therapy. The Researchers Found That Statins Reduced Isoprenoid Production, Protein Prenylation, And YES-Associated Protein (YAP) Signaling. @MedicalNewsToday
Fathers’ Adverse Childhood Experiences Linked to Behavior Problems in Children ▫️Children Whose Fathers Reported One or More Adverse Childhood experiences (ACEs) Had A Higher Likelihood of Having Behavior Problems Than Children Whose Fathers Reported None. ▫️It Was Published Online on June 24, 2026, in The American Journal of Preventive Medicine. @MedicalNewsToday
Johns Hopkins Scientists Develop Nose Spray DNA Vaccine For Tuberculosis ▫️Researchers at Johns Hopkins Medicine And The Johns Hopkins Bloomberg School of Public Health Have Developed An Experimental Therapeutic DNA Vaccine For Tuberculosis (TB) That Is Delivered Through The Nose. ▫️The Vaccine Is Designed to Help The Immune System Identify And Attack Drug-Tolerant TB Bacteria Known As "Persisters," Which Can Surviv…
Showing the 12 most recent of 20 posts we hold for @MedicalNewsToday. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.
Mentions
Named by 2 registered channels — every channel on the register whose own posts have named this one, by its current username or any other username it currently holds, merged from two separately captured readings of the same fact so a namer caught by only one of them is not missed and a namer both caught is not counted twice. A username this channel has since dropped is not matched — that handle may belong to someone else now, and crediting today’s namer to yesterday’s owner would misattribute it.
Named by
Channels on the register whose posts name this channel's handle.
A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.
Cite this entry
A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 10 September 2026 — this entry's latest reading, not the date you are reading this.
“Medical News Today” (@MedicalNewsToday), 777 subscribers as measured 10 September 2026. Telegram Register, tgregister.com/channel/MedicalNewsToday.
Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.